NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

PI Industries Share Price Plunges 7% Amid Weak Financial Results

PI Industries' share price saw a significant decline of 7% on the National Stock Exchange (NSE) on Wednesday, following the company's weak financial results for the quarter ended March 31, 2026. The stock opened at ₹2,950 apiece, down from the previous close of ₹3,124 per share on Tuesday. It touched an intraday low of ₹2,860.10.

Disappointing Financial Results

For the March quarter, PI Industries reported a 12% year-on-year (YoY) decline in revenue to ₹1,565 crore, which was broadly in line with market expectations. However, the company's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) fell 26% to ₹337 crore, compared to the Street's expectation of a 19% decline from the previous year. The EBITDA margin narrowed to 21.5% from 25.4% a year ago, missing analyst estimates of 23%.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Financial MetricQ4 2026 (YoY)Analyst Estimate
Revenue₹1,565 crore-12%
EBITDA₹337 crore-19%
EBITDA Margin21.5%23%
Net Profit₹200 crore-23%

The company's net profit dropped 39% YoY to ₹200 crore from ₹331 crore, a steeper fall than estimated by analysts. For instance, Kotak Equities had projected a 23% decline in the bottomline.

Segment-wise Performance

Segment-wise, PI Industries' agrochemical exports declined 19% year-on-year, while volumes dropped 14% due to a high base effect. Domestic revenue decreased 7% from the previous year, with volumes down 1% owing to adverse weather conditions, weaker crop prices, regulatory disruptions in the biologicals segment, and higher channel inventory levels.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Share Price Trend

The company's share price has largely remained negative in the near term amid weak market sentiments. The stock has fallen by over 4.38% in a week and 4% in a month. Furthermore, the stock has descended 9.38% on a year-to-date (YTD) basis and 22% in a year. PI Industries shares have failed to impress long-term investors by plunging 11% in three years. However, the stock has delivered 13% returns in five years.

Brokerage Firm's View

Brokerage firm Motilal Oswal has assigned a 'buy' call with a target price of ₹3,125 apiece, saying weak operating performance was due to adverse operating leverage. The firm noted that the company's agrochemicals business revenue declined 14% YoY to ₹14.6 billion, while the Pharma business revenue rose 23% YoY to ₹1 billion.

Technical Outlook

On the technical outlook, Anshul Jain, Head of Research at Lakshmishree, said that PI Industries has been defending the 2850 zone for nearly 172 weeks, forming a long-term triple bottom structure that reflects strong demand absorption at lower levels. The current price action marks the fourth test of this crucial support band, making it a decisive inflection point for the broader trend.

Investor Takeaway

Investors should be cautious of PI Industries' disappointing Q4 earnings and potential impact on its stock price.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.